van Creij, N. C. H., Tymoszuk, P., Handle, F., Seeber, A., Sellemond, T., Martowicz, A., . . . Pichler, R. (2026). Multi‐omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy. Clinical & Translational Medicine, 16(3), 1. https://doi.org/10.1002/ctm2.70638
Chicago Style (17th ed.) Citationvan Creij, Nils C. H., et al. "Multi‐omic Profiling Defines Three Distinct Molecular Subtypes of Urothelial Carcinoma with Implications for Precision Therapy." Clinical & Translational Medicine 16, no. 3 (2026): 1. https://doi.org/10.1002/ctm2.70638.
MLA (9th ed.) Citationvan Creij, Nils C. H., et al. "Multi‐omic Profiling Defines Three Distinct Molecular Subtypes of Urothelial Carcinoma with Implications for Precision Therapy." Clinical & Translational Medicine, vol. 16, no. 3, 2026, p. 1, https://doi.org/10.1002/ctm2.70638.